17th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170112843 | COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS | 2017-04-27 |
20170112844 | Benzimidazole Derivatives As PI3 Kinase Inhibitors | 2017-04-27 |
20170112845 | sGC STIMULATORS | 2017-04-27 |
20170112846 | OXYGEN LINKED PYRIMIDINE DERIVATIVES | 2017-04-27 |
20170112847 | EMULSION FORMULATIONS OF APREPITANT | 2017-04-27 |
20170112848 | THERAMUTEIN MODULATORS | 2017-04-27 |
20170112849 | Method of Treatment Using Substituted Imidazo[1,2b]Pyridazine Compounds | 2017-04-27 |
20170112850 | Pharmaceutical Composition Comprising Licarbazepine Acetate | 2017-04-27 |
20170112851 | HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL | 2017-04-27 |
20170112852 | DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM) | 2017-04-27 |
20170112853 | Hypotensive Lipid And Timolol Compositions And Methods Of Using Same | 2017-04-27 |
20170112854 | Misoprostol Composition | 2017-04-27 |
20170112855 | NOVEL THERAPEUTIC COMPOSITION | 2017-04-27 |
20170112856 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER IN AN INDIVIDUAL SUBJECT SUFFERING CANCER | 2017-04-27 |
20170112857 | Extended Release Aspirin | 2017-04-27 |
20170112858 | Extended Release Aspirin | 2017-04-27 |
20170112859 | METHOD OF TREATMENT USING AN ASSOCIATION OF LOSARTAN AND ACETYLSALICYLIC ACID, AND KIT | 2017-04-27 |
20170112860 | NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHODS FOR TREATING BRAIN SWELLING | 2017-04-27 |
20170112861 | DRUG DELIVERY ENHANCER COMPRISING SUBSTANCE FOR ACTIVATING LYSOPHOSPHOLIPID RECEPTORS | 2017-04-27 |
20170112862 | METHOD FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA | 2017-04-27 |
20170112863 | NEW COMPOSITION | 2017-04-27 |
20170112864 | Thyromimetics for the Treatment of Fatty Liver Diseases | 2017-04-27 |
20170112865 | TREATMENT FOR MELANOMA | 2017-04-27 |
20170112866 | ANTI-TUMOR AGENT CONTAINING TAXANE COMPOUND, AND ANTI-TUMOR EFFECT ENHANCER | 2017-04-27 |
20170112867 | PHARMACEUTICAL COMBINATIONS OF SOFOSBUVIR AND RIBAVIRIN | 2017-04-27 |
20170112868 | 2'-Ethynyl Nucleoside Derivatives for Treatment of Viral Infections | 2017-04-27 |
20170112869 | COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS | 2017-04-27 |
20170112870 | ALGIN OLIGOSACCHARIDES AND THE DERIVATIVES THEREOF AS WELL AS THE MANUFACTURE AND THE USE OF THE SAME | 2017-04-27 |
20170112871 | VETERINARY METHODS FOR USING NITRIC OXIDE IN A PLASMA STATE TO TREAT MEDICAL CONDITIONS AND DISEASES IN ANIMALS | 2017-04-27 |
20170112872 | METHODS OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION | 2017-04-27 |
20170112873 | Method and Topical Composition for the Treatment of Rosacea and Skin Erythema Using Selenium Sulfide | 2017-04-27 |
20170112874 | Therapeutic Methods And Pharmaceutical Compositions For Treating Warts With Tellurium Compounds | 2017-04-27 |
20170112875 | MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS | 2017-04-27 |
20170112876 | METHOD OF SELECTING PHOSPHATE BINDER AND ITS USES THEREOF | 2017-04-27 |
20170112877 | NON-TOXIC AGENT FOR A BROAD-SPECTRUM, BACTERICIDAL OR BACTERIOSTATIC TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA IN ANIMALS | 2017-04-27 |
20170112878 | PROGRAMMABLE UNIVERSAL CELL RECEPTORS AND METHOD OF USING THE SAME | 2017-04-27 |
20170112879 | METHODS OF PROTECTION AGAINST ISCHEMIA REPERFUSION INJURY | 2017-04-27 |
20170112880 | CARDIAC CELL CULTURE MATERIAL | 2017-04-27 |
20170112881 | Method of Treating Endometriosis | 2017-04-27 |
20170112882 | INHIBITING OR REDUCING FUNGAL INFECTIONS | 2017-04-27 |
20170112883 | A COMPOSITION FOR USE IN TREATING OR PREVENTING VIRAL OR BACTERIAL INFECTIONS IN A SUBJECT UNDERGOING ANTI-TUMOR CHEMOTHERAPY, LEUKEMIA TREATMENT OR AIDS THERAPY COMPRISING L. REUTERI LER03 AND/OR L. SALIVARIUS LS06 | 2017-04-27 |
20170112884 | ENERGY COMPOSITION | 2017-04-27 |
20170112885 | HERBAL FORMULATIONS OF CARNIVOROUS PLANTS AND METHODS FOR TREATING INFLAMMATION | 2017-04-27 |
20170112886 | COMPOSITION CONTAINING ARONIA BERRY EXTRACT, RED SPINACH EXTRACT AND BEETROOT EXTRACT | 2017-04-27 |
20170112887 | METHOD FOR THE ATTENUATION OF ATHEROSCLEROSIS CONDITION(S) USING LICORICE EXTRACT AS A MEDICAMENT | 2017-04-27 |
20170112888 | EYE LENS AND METHOD FOR MAKING SAME | 2017-04-27 |
20170112889 | POWDER FOR DELIVERY TO THE ORAL CAVITY | 2017-04-27 |
20170112890 | Peptides and Compositions Thereof for Improvement of Glycaemic Management in a Mammal | 2017-04-27 |
20170112891 | HINDERED DISULFIDE DRUG CONJUGATES | 2017-04-27 |
20170112892 | RETINYLAMINE DERIVITIVES FOR TREATMENT OF OCULAR DISORDERS | 2017-04-27 |
20170112893 | METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY | 2017-04-27 |
20170112894 | PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION WITH T CELL ACTIVATING AND/OR CHECKPOINT INHIBITING AGENTS FOR CANCER TREATMENT | 2017-04-27 |
20170112895 | PHARMACEUTICAL FORMULATIONS | 2017-04-27 |
20170112896 | SMALL MOLECULE RAC OR RHO INHIBITORS | 2017-04-27 |
20170112897 | METHODS FOR TREATING BRAIN INSULIN RESISTANCE | 2017-04-27 |
20170112898 | FORMULATIONS OF HEPALATIDE | 2017-04-27 |
20170112899 | POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF | 2017-04-27 |
20170112900 | METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING BINDING OF IL-4 AND/OR IL-13 TO THEIR RESPECTIVE RECEPTORS | 2017-04-27 |
20170112901 | LIQUID PHARMACEUTICAL COMPOSITION OF CONJUGATED ERYTHROPOIETIN | 2017-04-27 |
20170112902 | REMEDIES FOR AMYOTROPHIC LATERAL SCLEROSIS | 2017-04-27 |
20170112903 | LYOPHILIZED PHARMACEUTICAL COMPOSITION OF FC-PEPTIDE FUSION PROTEIN | 2017-04-27 |
20170112904 | GLUCAGON RECEPTOR AGONISTS | 2017-04-27 |
20170112905 | SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM) | 2017-04-27 |
20170112906 | STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS | 2017-04-27 |
20170112907 | NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT | 2017-04-27 |
20170112908 | VACCINE | 2017-04-27 |
20170112909 | HER2 ANTIGENIC POLYPEPTIDE COMPOSITIONS, AND METHODS FOR THEIR USE IN TREATMENT AND PREVENTION OF CARCINOMAS | 2017-04-27 |
20170112910 | PROTEIN NANOPARTICLE LINKED WITH CANCER SPECIFIC EPITOPE AND COMPOSITION FOR CANCER IMMUNOTHERAPY COMPRISING THE SAME | 2017-04-27 |
20170112911 | Antigen-Specific T Cell Receptors and T Cell Epitopes | 2017-04-27 |
20170112912 | VACCINATION COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USE | 2017-04-27 |
20170112913 | NEW METHOD FOR PRODUCING OUTER MEMBRANE VESICLES | 2017-04-27 |
20170112914 | NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE | 2017-04-27 |
20170112915 | COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS | 2017-04-27 |
20170112916 | Gene Optimized Hantaan Virus M Segment DNA Vaccine For Hemorrhagic Fever With Renal Syndrome | 2017-04-27 |
20170112917 | PEPTIDE SCAFFOLD DESIGN | 2017-04-27 |
20170112918 | Allergy Inhibitor Compositions And Kits And Methods Of Using The Same | 2017-04-27 |
20170112919 | MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME | 2017-04-27 |
20170112920 | MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME | 2017-04-27 |
20170112921 | MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME | 2017-04-27 |
20170112922 | VESICULAR STOMATITIS VIRUS FOR PRIME BOOST VACCINE | 2017-04-27 |
20170112923 | MULTI-VALENT ADJUVANT DISPLAY | 2017-04-27 |
20170112924 | SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF | 2017-04-27 |
20170112925 | METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS | 2017-04-27 |
20170112926 | COMBINATION THERAPIES USING ANTI-METABOLITES AND AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS | 2017-04-27 |
20170112927 | COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND ALKYLATING AGENTS | 2017-04-27 |
20170112928 | COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TOPOISOMERASE | 2017-04-27 |
20170112929 | VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER | 2017-04-27 |
20170112930 | Stable Protein-Containing Preparation Containing Argininamide or Analogous Compound Thereof | 2017-04-27 |
20170112931 | Conjugates Comprising an Anti-EGFR1 Antibody | 2017-04-27 |
20170112932 | COMPOSITION FOR SUSTAINED DRUG DELIVERY COMPRISING GEOPOLYMERIC BINDER | 2017-04-27 |
20170112933 | OPHTHALMIC COMPOSITION | 2017-04-27 |
20170112934 | AQUEOUS OPHTHALMIC COMPOSITION | 2017-04-27 |
20170112935 | MATERIAL AND METHOD FOR TREATING INTERNAL CAVITIES | 2017-04-27 |
20170112936 | PHARMACEUTICAL COMPOSITIONS COMPRISING GELS AND METHODS FOR FABRICATING THEREOF | 2017-04-27 |
20170112937 | METHOD FOR PRODUCING AQUEOUS OPHTHALMIC COMPOSITION, AND AQUEOUS OPHTHALMIC COMPOSITION | 2017-04-27 |
20170112938 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY | 2017-04-27 |
20170112939 | PREVENTION AND TREATMENT OF OCULAR CONDITIONS | 2017-04-27 |
20170112940 | Modified Collagen Hybridizing Peptides And Uses Thereof | 2017-04-27 |
20170112941 | VE-CADHERIN BINDING BIOCONJUGATE | 2017-04-27 |
20170112942 | CELL PENETRATING PEPTIDE, CONJUGATE COMPRISING SAME, AND COMPOSITION COMPRISING CONJUGATE | 2017-04-27 |